These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10744033)

  • 1. In vitro evidence that beta-amyloid peptide 1-40 diffuses across the blood-brain barrier and affects its permeability.
    Strazielle N; Ghersi-Egea JF; Ghiso J; Dehouck MP; Frangione B; Patlak C; Fenstermacher J; Gorevic P
    J Neuropathol Exp Neurol; 2000 Jan; 59(1):29-38. PubMed ID: 10744033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fate of cerebrospinal fluid-borne amyloid beta-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries.
    Ghersi-Egea JF; Gorevic PD; Ghiso J; Frangione B; Patlak CS; Fenstermacher JD
    J Neurochem; 1996 Aug; 67(2):880-3. PubMed ID: 8764620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Density Lipoprotein Mimetic Peptide 4F Efficiently Crosses the Blood-Brain Barrier and Modulates Amyloid-
    Swaminathan SK; Zhou AL; Ahlschwede KM; Curran GL; Lowe VJ; Li L; Kandimalla KK
    J Pharmacol Exp Ther; 2020 Nov; 375(2):308-316. PubMed ID: 32778535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain.
    Swaminathan SK; Ahlschwede KM; Sarma V; Curran GL; Omtri RS; Decklever T; Lowe VJ; Poduslo JF; Kandimalla KK
    J Cereb Blood Flow Metab; 2018 May; 38(5):904-918. PubMed ID: 28569090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid beta peptide in aged squirrel monkey with cerebral amyloid angiopathy.
    Mackic JB; Weiss MH; Miao W; Kirkman E; Ghiso J; Calero M; Bading J; Frangione B; Zlokovic BV
    J Neurochem; 1998 Jan; 70(1):210-5. PubMed ID: 9422364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions.
    Mackic JB; Bading J; Ghiso J; Walker L; Wisniewski T; Frangione B; Zlokovic BV
    Vascul Pharmacol; 2002 Jun; 38(6):303-13. PubMed ID: 12529925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active clearance of human amyloid beta 1-42 peptide aggregates from the rat ventricular system.
    Nakagawa Y; Yuzuriha T; Iwaki T
    Neuropathology; 2004 Sep; 24(3):194-200. PubMed ID: 15484697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: usage of a novel blood brain barrier endothelial cell model system.
    Davies TA; Long HJ; Eisenhauer PB; Hastey R; Cribbs DH; Fine RE; Simons ER
    Amyloid; 2000 Sep; 7(3):153-65. PubMed ID: 11019856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier.
    Bachmeier C; Beaulieu-Abdelahad D; Mullan M; Paris D
    Mol Cell Neurosci; 2013 Sep; 56():255-62. PubMed ID: 23831388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
    Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
    Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of glucose transport at the blood-brain barrier: an in vitro study.
    McAllister MS; Krizanac-Bengez L; Macchia F; Naftalin RJ; Pedley KC; Mayberg MR; Marroni M; Leaman S; Stanness KA; Janigro D
    Brain Res; 2001 Jun; 904(1):20-30. PubMed ID: 11516408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport of human beta-amyloid peptide through the rat blood-brain barrier after global cerebral ischemia.
    Pluta R; Misicka A; Januszewski S; Barcikowska M; Lipkowski AW
    Acta Neurochir Suppl; 1997; 70():247-9. PubMed ID: 9416336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro.
    Baysal I; Ucar G; Gultekinoglu M; Ulubayram K; Yabanoglu-Ciftci S
    J Neural Transm (Vienna); 2017 Jan; 124(1):33-45. PubMed ID: 26911385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer.
    Mackic JB; Stins M; McComb JG; Calero M; Ghiso J; Kim KS; Yan SD; Stern D; Schmidt AM; Frangione B; Zlokovic BV
    J Clin Invest; 1998 Aug; 102(4):734-43. PubMed ID: 9710442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible reverse transport of beta-amyloid peptide across the blood-brain barrier.
    Pluta R; Misicka A; Barcikowska M; Spisacka S; Lipkowski AW; Januszewski S
    Acta Neurochir Suppl; 2000; 76():73-7. PubMed ID: 11450095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celecoxib Prevents Cognitive Impairment and Neuroinflammation in Soluble Amyloid β-treated Rats.
    Mhillaj E; Morgese MG; Tucci P; Furiano A; Luongo L; Bove M; Maione S; Cuomo V; Schiavone S; Trabace L
    Neuroscience; 2018 Feb; 372():58-73. PubMed ID: 29306052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Amyloid-β
    Peng HB; Noh K; Pan SR; Saldivia V; Serson S; Toscan A; de Lannoy IAM; Pang KS
    Drug Metab Dispos; 2020 Oct; 48(10):944-955. PubMed ID: 32759365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrillar amyloid beta-protein inhibits the activity of high molecular weight brain protease and trypsin.
    Chauhan V; Sheikh AM; Chauhan A; Spivack WD; Fenko MD; Malik MN
    J Alzheimers Dis; 2005 Feb; 7(1):37-44. PubMed ID: 15750213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of the blood-brain barrier by pentosan against amyloid-β-induced toxicity.
    Deli MA; Veszelka S; Csiszár B; Tóth A; Kittel A; Csete M; Sipos A; Szalai A; Fülöp L; Penke B; Abrahám CS; Niwa M
    J Alzheimers Dis; 2010; 22(3):777-94. PubMed ID: 20847411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor.
    Wu D; Yang J; Pardridge WM
    J Clin Invest; 1997 Oct; 100(7):1804-12. PubMed ID: 9312181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.